Skip to Main Content

Paper Details

Phase II trial of sorafenib in metastatic thyroid cancer.
J Clin Oncol
414
2009
Author NameAffiliation
Richard T KloosOhio State University, Center for Biostatistics
  • 1 - 1

Datasets

Release 1.2